TNG260

· Tango Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TNG260, covering 2025-11-18 to 2025-11-18. Get the full timeline:

Most recent: Clinical Trial Update: Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors [Phase 1, Phase 2]